Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tenon Medical (TNON) EBITDA Margin (2021 - 2025)

Tenon Medical (TNON) has 5 years of EBITDA Margin data on record, last reported at 284.65% in Q3 2025.

  • For Q3 2025, EBITDA Margin rose 7431.0% year-over-year to 284.65%; the TTM value through Sep 2025 reached 396.26%, up 1454.0%, while the annual FY2024 figure was 415.84%, 11446.0% up from the prior year.
  • EBITDA Margin reached 284.65% in Q3 2025 per TNON's latest filing, up from 490.96% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 284.65% in Q3 2025 and bottomed at 7568.18% in Q2 2021.
  • Average EBITDA Margin over 5 years is 1829.61%, with a median of 574.56% recorded in 2023.
  • Peak YoY movement for EBITDA Margin: crashed -198075bps in 2022, then skyrocketed 352618bps in 2023.
  • A 5-year view of EBITDA Margin shows it stood at 5362.26% in 2021, then surged by 47bps to 2829.24% in 2022, then skyrocketed by 87bps to 380.94% in 2023, then dropped by -5bps to 400.91% in 2024, then grew by 29bps to 284.65% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 284.65% in Q3 2025, 490.96% in Q2 2025, and 498.07% in Q1 2025.